Home > Healthcare > Medical Devices > Diagnostic Devices > HLA Typing for Transplant Market

HLA Typing for Transplant Market Share

  • Report ID: GMI1653
  • Published Date: Nov 2022
  • Report Format: PDF

HLA Typing for Transplant Market Share

Some of the leading companies in the HLA typing for transplant market are

  • Luminex Corporation
  • Pacific Biosciences of California, Inc
  • Abbott Laboratories
  • Bio-Rad Laboratories
  • BioReference Laboratories
  • CareDx, Inc.
  • GenDx
  • Illumina Inc.
  • Fujirebio
  • BAG Diagnostic GmbH
  • Immucor Inc.
  • Inno-train Diagnostik GmbH
  • Omixon, Inc.
  • Qiagen N.V.
  • F. Hoffmann-La Roche Ltd
  • Thermo-Fisher Scientific Inc.
  • GMSbiotech, Inc.
  • Biofortuna Limited
  • TBG Diagnostics Limited
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market for HLA typing for transplant was worth more than USD 735 million in 2022 and is projected to exhibit over 8.5% CAGR from 2023-2032.

Software is anticipated to reach over USD 250 million by 2032 owing to the development of sophisticated software for data analysis.

North America HLA typing for transplant market was more than 35% in 2022 and is projected to witness substantial growth on account of surging demand for organ transplantation.

Luminex Corporation, Abbott Laboratories, CareDx, Inc., GenDx, Illumina Inc., Immucor Inc., and Biofortuna Limited are some of the major companies in the global market.

HLA Typing for Transplant Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2022
  • Companies covered: 19
  • Tables & Figures: 372
  • Countries covered: 15
  • Pages: 255
 Download Free Sample